Diagnostic Nuclear Medicines Market Report

Global and Region Diagnostic Nuclear Medicines Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：170
  • REPORT CODE：GMM993417
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis

    The report details the trend, potential and market size of Diagnostic Nuclear Medicines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Diagnostic Nuclear Medicinesmarket, defines the market attractiveness level of Diagnostic Nuclear Medicines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Diagnostic Nuclear Medicines industry, describes the types of Diagnostic Nuclear Medicines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Diagnostic Nuclear Medicines market and the development prospects and opportunities of Diagnostic Nuclear Medicines industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Diagnostic Nuclear Medicines market in Chapter 13.

    By Player:

    • Triad Isotopes

    • Jubilant Pharma

    • Curium Pharmaceuticals

    • China Isotope & Radiation

    • Navidea

    • Dongcheng

    • Lantheus

    • SIEMENS

    • GE Healthcare

    • Bayer

    • Eli Lilly

    • Novartis

    • Bracco Imaging

    • Nordion

    By Type:

    • Tc-99m

    • F-18

    • Other

    By End-User:

    • Oncology

    • Cardiology

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Diagnostic Nuclear Medicines Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Diagnostic Nuclear Medicines Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Diagnostic Nuclear Medicines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Diagnostic Nuclear Medicines Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Diagnostic Nuclear Medicines Market Analysis and Outlook to 2022

    • 7.1 Global Diagnostic Nuclear Medicines Consumption (2017-2022)

    • 7.2 United States Diagnostic Nuclear Medicines Consumption (2017-2022)

    • 7.3 Europe Diagnostic Nuclear Medicines Consumption (2017-2022)

    • 7.4 China Diagnostic Nuclear Medicines Consumption (2017-2022)

    • 7.5 Japan Diagnostic Nuclear Medicines Consumption (2017-2022)

    • 7.6 India Diagnostic Nuclear Medicines Consumption (2017-2022)

    • 7.7 South Korea Diagnostic Nuclear Medicines Consumption (2017-2022)

    8 Region and Country-wise Diagnostic Nuclear Medicines Market Analysis and Outlook to 2028

    • 8.1 Global Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)

    • 8.2 United States Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)

    • 8.3 Europe Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)

    • 8.4 China Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)

    • 8.5 Japan Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)

    • 8.6 India Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)

    • 8.7 South Korea Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)

    9 Global Diagnostic Nuclear Medicines Market Outlook by Types and Applications to 2022

    • 9.1 Global Diagnostic Nuclear Medicines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Tc-99m Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global F-18 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Diagnostic Nuclear Medicines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cardiology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Diagnostic Nuclear Medicines Market Outlook by Types and Applications to 2028

    • 10.1 Global Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Tc-99m Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global F-18 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Diagnostic Nuclear Medicines Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Diagnostic Nuclear Medicines Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Diagnostic Nuclear Medicines Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Diagnostic Nuclear Medicines Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Diagnostic Nuclear Medicines Market Competitive Analysis

    • 14.1 Triad Isotopes

      • 14.1.1 Triad Isotopes Company Details

      • 14.1.2 Triad Isotopes Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Triad Isotopes Diagnostic Nuclear Medicines Product and Service

    • 14.2 Jubilant Pharma

      • 14.2.1 Jubilant Pharma Company Details

      • 14.2.2 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Jubilant Pharma Diagnostic Nuclear Medicines Product and Service

    • 14.3 Curium Pharmaceuticals

      • 14.3.1 Curium Pharmaceuticals Company Details

      • 14.3.2 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Product and Service

    • 14.4 China Isotope & Radiation

      • 14.4.1 China Isotope & Radiation Company Details

      • 14.4.2 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 China Isotope & Radiation Diagnostic Nuclear Medicines Product and Service

    • 14.5 Navidea

      • 14.5.1 Navidea Company Details

      • 14.5.2 Navidea Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Navidea Diagnostic Nuclear Medicines Product and Service

    • 14.6 Dongcheng

      • 14.6.1 Dongcheng Company Details

      • 14.6.2 Dongcheng Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Dongcheng Diagnostic Nuclear Medicines Product and Service

    • 14.7 Lantheus

      • 14.7.1 Lantheus Company Details

      • 14.7.2 Lantheus Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Lantheus Diagnostic Nuclear Medicines Product and Service

    • 14.8 SIEMENS

      • 14.8.1 SIEMENS Company Details

      • 14.8.2 SIEMENS Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 SIEMENS Diagnostic Nuclear Medicines Product and Service

    • 14.9 GE Healthcare

      • 14.9.1 GE Healthcare Company Details

      • 14.9.2 GE Healthcare Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GE Healthcare Diagnostic Nuclear Medicines Product and Service

    • 14.10 Bayer

      • 14.10.1 Bayer Company Details

      • 14.10.2 Bayer Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bayer Diagnostic Nuclear Medicines Product and Service

    • 14.11 Eli Lilly

      • 14.11.1 Eli Lilly Company Details

      • 14.11.2 Eli Lilly Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Eli Lilly Diagnostic Nuclear Medicines Product and Service

    • 14.12 Novartis

      • 14.12.1 Novartis Company Details

      • 14.12.2 Novartis Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Novartis Diagnostic Nuclear Medicines Product and Service

    • 14.13 Bracco Imaging

      • 14.13.1 Bracco Imaging Company Details

      • 14.13.2 Bracco Imaging Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Bracco Imaging Diagnostic Nuclear Medicines Product and Service

    • 14.14 Nordion

      • 14.14.1 Nordion Company Details

      • 14.14.2 Nordion Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Nordion Diagnostic Nuclear Medicines Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Diagnostic Nuclear Medicines

    • Figure Diagnostic Nuclear Medicines Picture

    • Table Global Diagnostic Nuclear Medicines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Diagnostic Nuclear Medicines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Diagnostic Nuclear Medicines Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Diagnostic Nuclear Medicines Consumption by Country (2017-2022)

    • Figure United States Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)

    • Table Europe Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)

    • Figure China Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)

    • Figure Japan Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)

    • Figure India Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Nuclear Medicines Consumption Forecast by Country (2022-2028)

    • Figure United States Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tc-99m Consumption and Growth Rate (2017-2022)

    • Figure Global F-18 Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiology Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Tc-99m Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global F-18 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Diagnostic Nuclear Medicines Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Diagnostic Nuclear Medicines Export by Region (Top 5 Countries) (2017-2028)

    • Table Triad Isotopes (Foundation Year, Company Profile and etc.)

    • Table Triad Isotopes Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Triad Isotopes Diagnostic Nuclear Medicines Product and Service

    • Table Jubilant Pharma (Foundation Year, Company Profile and etc.)

    • Table Jubilant Pharma Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jubilant Pharma Diagnostic Nuclear Medicines Product and Service

    • Table Curium Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Product and Service

    • Table China Isotope & Radiation (Foundation Year, Company Profile and etc.)

    • Table China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Isotope & Radiation Diagnostic Nuclear Medicines Product and Service

    • Table Navidea (Foundation Year, Company Profile and etc.)

    • Table Navidea Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Navidea Diagnostic Nuclear Medicines Product and Service

    • Table Dongcheng (Foundation Year, Company Profile and etc.)

    • Table Dongcheng Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dongcheng Diagnostic Nuclear Medicines Product and Service

    • Table Lantheus (Foundation Year, Company Profile and etc.)

    • Table Lantheus Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Diagnostic Nuclear Medicines Product and Service

    • Table SIEMENS (Foundation Year, Company Profile and etc.)

    • Table SIEMENS Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table SIEMENS Diagnostic Nuclear Medicines Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Diagnostic Nuclear Medicines Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Diagnostic Nuclear Medicines Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Diagnostic Nuclear Medicines Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Diagnostic Nuclear Medicines Product and Service

    • Table Bracco Imaging (Foundation Year, Company Profile and etc.)

    • Table Bracco Imaging Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Imaging Diagnostic Nuclear Medicines Product and Service

    • Table Nordion (Foundation Year, Company Profile and etc.)

    • Table Nordion Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordion Diagnostic Nuclear Medicines Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US